Literature DB >> 12640253

Phospholipase C activity is enhanced in skin fibroblasts obtained from patients with essential hypertension.

Takuo Kosugi1, Tomohiro Osanai, Takaatsu Kamada, Takao Nakano, Ken Okumura.   

Abstract

OBJECTIVES: In human hypertension, the response of phospholipase C (PLC) to stimuli is enhanced in signal transduction where receptors are coupled to pertussis toxin-sensitive G protein. We investigated PLC activity and its role in human hypertension. METHODS AND
RESULTS: Skin fibroblasts were cultured from 15 normotensives subjects (53 +/- 4 years, four men and 11 women) and 19 essential hypertension (EH) patients (58 +/- 2 years, nine men and 10 women). Plasma membrane PLC activity, assessed by conversion of the tritiated exogenous phosphatidylinositol-4,5-bisphosphate to inositol trisphosphate, was greater in EH patients than in normotensive subjects (1.4 +/- 0.2 versus 0.7 +/- 0.1 pmol/mg protein/min, P <0.05). There was a positive correlation between PLC activity and mean blood pressure measured at admission and 7 days after admission (r = 0.47 and 0.37 respectively, both P <0.05). The value of the Michaelis constant was lower in EH patients than in normotensive subjects (32.1 +/- 5.6 versus 58.3 +/- 10.0 micromol/l, P <0.05), despite the fact that maximal velocity of the reaction was no different. Western blot analysis against PLC beta2 and beta3, gamma, delta1, and G protein gamma2 and gamma5 revealed that most PLC and G protein isoforms detected were delta1 of PLC and gamma2 of G protein, and no difference was detected in their amount between two groups.
CONCLUSIONS: We conclude that enhanced PLC delta1 activity may be involved in the pathogenesis of human hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640253     DOI: 10.1097/00004872-200303000-00025

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

2.  Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1.

Authors:  Christopher J Clarke; Simon Forman; James Pritchett; Vasken Ohanian; Jacqueline Ohanian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

3.  Phospholipase C-delta extends intercellular signalling range and responses to injury-released growth factors in non-excitable cells.

Authors:  L Y Mi; D S Ettenson; E R Edelman
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

4.  Fibroblasts as an experimental model system for the study of comparative physiology.

Authors:  Carla B Madelaire; Amy C Klink; William J Israelsen; Allyson G Hindle
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2022-03-20       Impact factor: 2.495

5.  Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm.

Authors:  Takahiko Kinjo; Makoto Tanaka; Tomohiro Osanai; Shuji Shibutani; Ikuyo Narita; Tomohiro Tanno; Kimitaka Nishizaki; Hiroaki Ichikawa; Yoshihiro Kimura; Yuji Ishida; Takashi Yokota; Michiko Shimada; Yoshimi Homma; Hirofumi Tomita; Ken Okumura
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.